Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Efavirenz + Emtricitabine + TDF bulk supplier for pharma manufacturers

Efavirenz + Emtricitabine + Tdf 600/200/300 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 600/200/300 mg

Reference Brands: Atripla(US/EU)

Category: Anti Viral

Atripla Tablets (Efavirenz 600 mg, Emtricitabine 200 mg, Tenofovir 300 mg) offer a once-daily, fixed-dose HIV treatment. Available via PharmaB2B platforms from WHO-GMP and USFDA-approved suppliers, Atripla is ideal for bulk procurement, tenders, and HIV programs. Ensure reliable supply from trusted global manufacturers.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Atripla Tablets combine Efavirenz (600 mg), Emtricitabine (200 mg), and Tenofovir Disoproxil Fumarate (300 mg) in a once-daily, fixed-dose antiretroviral therapy for HIV-1 infection. Widely recommended in global HIV treatment guidelines, Atripla simplifies adherence and improves patient outcomes. On PharmaB2B platforms, global pharmaceutical buyers, NGOs, and procurement agencies can source WHO-GMP and USFDA-approved Atripla formulations from trusted manufacturers. Ideal for tender supply, HIV programs, and institutional purchases, Atripla is available for bulk export at competitive prices. Partner with verified suppliers on PharmaB2B to ensure timely, compliant delivery of high-quality antiretrovirals essential for public health programs.

Efavirenz + Emtricitabine + Tdf — third party manufacturing & bulk supply

Efavirenz + Emtricitabine + Tdf 600/200/300 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Efavirenz + Emtricitabine + Tdf is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Efavirenz + Emtricitabine + Tdf listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Efavirenz + Emtricitabine + Tdf →
Back to Listing

Frequently Asked Questions

Efavirenz, emtricitabine, and tenofovir disoproxil fumarate (TDF) are used together as a single-tablet regimen to treat HIV-1 infection. This combination helps lower viral load, improve immune function, and prevent HIV progression when taken regularly.

It is made from three antiretroviral agents: efavirenz (a non-nucleoside reverse transcriptase inhibitor), emtricitabine (an NRTI), and tenofovir disoproxil fumarate (an NRTI). Together they block HIV replication at multiple stages.

The common trade name is Atripla.

Atripla is co-developed by Gilead Sciences and Bristol-Myers Squibb, with several generic manufacturers producing it globally.

The generic name is efavirenz, emtricitabine, and tenofovir disoproxil fumarate.

The primary brand name is Atripla.

It is manufactured in approved facilities in the USA, Europe, and India, depending on whether it is the innovator or a generic version.

Related Products

Efavirenz

Strength:
Tab: 200 mg, 600 mg; Cap: 50 mg, 100 mg, 200 mg

Form: Tablet & Capsule

Reference Brands: Sustiva®(US); Stocrin®(EU)

View Details
Lamivudine & Zidovudine

Strength:
Lamivudine 150 mg + Zidovudine 300 mg

Form: Tablet

Reference Brands: Combivir®(US/ EU)

View Details
Atazanavir & Ritonavir

Strength:
300 mg Atazanavir + 100 mg Ritonavir

Form: Tablets

Reference Brands: Evotaz®(US)

View Details
Lamivudine

Strength:
Tab:150 mg, 300 mg; Oral solution:10 mg/mL

Form: Tablet & Oral solution

Reference Brands: Epivir®(US/EU)

View Details
Valaciclovir Tablets

Strength:
500mg, 1000mg

Form: Tablets

Reference Brands: Valtrex (USA/EU/UK), Zelitrex (EU)

View Details
Valganciclovir Tablets

Strength:
450mg

Form: Tablets

Reference Brands: Valcyte (USA/EU/UK), Rovalcyte

View Details
Abacavir Sulphate Tablets

Strength:
300 mg, 600 mg

Form: Tablets

Reference Brands: Ziagen (USA/EU)

View Details
Atazanavir & Ritonavir Tablets

Strength:
300 mg + 100 mg

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.